Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRheumatology Physician in Boston, MA
NPI: 1053346924Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Physicians Organization Inc
massgeneral.org
HQ Phone
Get M.D. John's Phone Numberphone_androidMobile
Get M.D. John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
MA State Medical License
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Rheumatology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 100 | 160 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 38 | 41 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 18 | 18 |
Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
Authors: Takashi Maehara, Hamid Mattoo, Miho Ohta, Vinay Mahajan, Masafumi Moriyama, Masaki Yamauchi, Jefte Drijvers, Seiji Nakamura, John Stone, Shiv Pillai
Publication Date: 2016-01-08
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study.
Authors: Yicong Liang, Faith A Zeng, Tabrez Sheriff, Anna Wilson, Asli Bilgic, Grant Feng, John Stone, Dedee Murrell
Publication Date: 2021-09-10
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Bristol-Myers Squibb, Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Intervention / Treatment: DRUG: prednisone, DRUG: acetaminophen, DRUG: methylprednisolone, DRUG: elotuzumab, DRUG: diphenhydramine, DRUG: placebo for elotuzumab, DRUG: famotidine
Lead Sponsor: Massachusetts General Hospital
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Abatacept
Lead Sponsor: Massachusetts General Hospital
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Tocilizumab, DRUG: Placebos
